Dysthymia and chronic depressive states: diagnostic and pharmacotherapeutic considerations. Overview of the diagnosis, prevalence, and comorbidity of dysthymia.

Psychopharmacol Bull

Mood, Anxiety, and Personality Disorders Research Branch, NIMH, Rockville, MD 20857.

Published: December 1994

Download full-text PDF

Source

Publication Analysis

Top Keywords

dysthymia chronic
4
chronic depressive
4
depressive states
4
states diagnostic
4
diagnostic pharmacotherapeutic
4
pharmacotherapeutic considerations
4
considerations overview
4
overview diagnosis
4
diagnosis prevalence
4
prevalence comorbidity
4

Similar Publications

Assessing the efficacy of metacognitive therapy as monotherapy or adjunctive treatment in patient suffering from major depression and dysthimia: A comprehensive review of clinical trials.

J Affect Disord

February 2025

Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Department of Neurosciences and Mental Health, 20122 Milan, Italy. Electronic address:

Background: Depression is one of the most widespread diseases worldwide, with the highest rates of disability. Considering its chronic course, over the years several treatment options have been developed and validated, however still with high relapse rates. Therefore, in recent years, the so-called third wave psychotherapies have been developed for the treatment of psychiatric disorders.

View Article and Find Full Text PDF
Article Synopsis
  • This study examined the demographics and comorbidities of patients with narcolepsy by analyzing electronic health records (EHR) using natural language processing (NLP) algorithms, marking a novel approach in this area.
  • Researchers identified 2,057 narcolepsy patients at the Mayo Clinic from 2000 to 2020 and compared them with a matched control group, focusing on various comorbid conditions.
  • The findings revealed that narcolepsy patients have higher instances of sleep disorders, mood disorders, and pain-related conditions, indicating that their challenges extend beyond just narcolepsy symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • Child maltreatment is a major risk factor for mental and physical health issues, and certain therapeutic approaches, like CBASP, aim to address these risks specifically for conditions like chronic depression.
  • This study analyzed data from a previous clinical trial involving patients with early-onset chronic depression to understand how patterns of child maltreatment might predict therapy outcomes between CBASP and supportive psychotherapy.
  • Using a clustering approach from childhood trauma data, the research sought to determine if different maltreatment histories could lead to varying levels of improvement in depression symptoms over a two-year period post-treatment.
View Article and Find Full Text PDF

Purpose: We examined the correlates of disability among people with non-communicable diseases (NCDs) and comorbid common mental disorders (CMDs) from rural India.

Methods: The sample comprised 2,486 participants enrolled in a cluster randomized trial (cRCT), Healthier OPtions through Empowerment (HOPE). Participants were 30 years or older, with a diagnosis of major depressive disorder, dysthymia, generalized anxiety disorder, and/or panic disorder on the MINI-International Neuropsychiatric Interview, with hypertension, diabetes, dsylipidemia and/ or ischemic heart disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!